首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella.
【24h】

Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella.

机译:原发性水痘患儿的侵袭性A组链球菌感染和非甾体抗炎药的使用。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIONS: To test the hypothesis that nonsteroidal antiinflammatory drug use increases the risk of necrotizing soft tissue infections and, secondarily, all invasive group A streptococcal (GAS) infections in children with primary varicella infection. METHODS: We conducted a prospective, multicenter case-control study among children <19 years old. Cases were children hospitalized with primary varicella complicated by invasive GAS infection or necrotizing soft tissue infection identified by a network of 45 pediatric infectious disease specialists located throughout the United States. Controls were children with uncomplicated primary varicella residing in the same communities as the cases. Data on medical history, clinical features of the varicella infection, signs and symptoms of infectious complications, and medication use were collected by structured telephone interviews. Univariate and multivariate matched odds ratios were calculated using conditional logistic regression. RESULTS: Between June 1996 and September 1998, 52 cases of invasive GAS infection, including 21 with necrotizing soft tissue infection, and 172 controls with uncomplicated primary varicella were enrolled. Risk of invasive GAS infection was increased among children who were nonwhite (multivariate odds ratio [OR] 3.8, 95% confidence interval [CI]: 1.4-11), living in low-income households (OR 5.1, 95% CI: 1.7-15), exposed to varicella at home (OR 6.4, 95% CI: 2.6-16), or had a persistent high fever (OR 9.6, 95% CI: 2.8-33). Antipyretic regimen was associated with several measures of varicella illness severity among the controls. The risk of necrotizing soft tissue infection was not associated with the use of ibuprofen before the development of signs or symptoms of this complication (OR 1.3, 95% CI: 0.33-5.3). Risk of any invasive GAS infection was increased among children who had received ibuprofen (OR 3.9, 95% CI: 1.3-12), but not acetaminophen (OR 1.2, 95% CI: 0.50-3.0). However, there was no evidence of increasing risk with increasing duration of ibuprofen use. Subgroup analyses revealed that the risk of invasive GAS infection was increased only among children who had received both acetaminophen and ibuprofen. CONCLUSIONS: These data do not support the hypothesis that nonsteroidal antiinflammatory drugs, or ibuprofen in particular, increase the risk of necrotizing GAS infections. A statistically significant association was observed between nonnecrotizing invasive GAS infection and ibuprofen use; however, because of potential confounding, the meaning of this unexpected result is unclear. Nonetheless, these data suggest that parents use ibuprofen or ibuprofen together with acetaminophen to treat high fever and severe illness, which seems to identify children at high risk for invasive GAS infection.
机译:目的:为了检验以下假设,即非甾体抗炎药的使用会增加坏死性软组织感染的风险,其次是原发性水痘感染儿童的所有侵袭性A组链球菌(GAS)感染。方法:我们对19岁以下的儿童进行了一项前瞻性,多中心病例对照研究。病例是由遍布美国的45名儿科传染病专家组成的网络确定的,儿童因原发性水痘并发侵袭性GAS感染或坏死性软组织感染而住院治疗。对照组是与病例相同的社区中患有简单水痘的儿童。通过结构性电话访谈收集有关病史,水痘感染的临床特征,感染并发症的体征和症状以及用药情况的数据。使用条件逻辑回归来计算单变量和多元匹配的优势比。结果:在1996年6月至1998年9月之间,共招募了52例侵袭性GAS感染,包括21例坏死性软组织感染和172例单纯性原发性水痘的对照。居住在低收入家庭中的非白人儿童(GA感染几率[OR] 3.8,95%置信区间[CI]:1.4-11)的风险增加(OR 5.1,95%CI:1.7- 15),在家中接触水痘(OR 6.4,95%CI:2.6-16),或持续发高烧(OR 9.6,95%CI:2.8-33)。解热方案与对照组中水痘病严重程度的几种测量方法相关。坏死软组织感染的风险与布洛芬的使用在此并发症的迹象或症状发展之前无关(OR 1.3,95%CI:0.33-5.3)。接受布洛芬(OR 3.9,95%CI:1.3-12)但对乙酰氨基酚(OR 1.2,95%CI:0.50-3.0)的儿童中,任何侵入性GAS感染的风险均增加。但是,没有证据表明布洛芬使用时间的增加会增加风险。亚组分析显示,侵入性GAS感染的风险仅在同时接受对乙酰氨基酚和布洛芬的儿童中增加。结论:这些数据不支持非甾体类抗炎药,特别是布洛芬,会增加坏死GAS感染的风险。非坏死性侵袭性GAS感染与布洛芬的使用之间存在统计学意义的相关性;但是,由于潜在的混淆,这种意外结果的含义尚不清楚。但是,这些数据表明,父母将布洛芬或布洛芬与对乙酰氨基酚一起用于治疗高烧和重症疾病,这似乎确定了侵入性GAS感染的高风险儿童。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号